Detected ·
Beeline Medicines
——
Beeline Medicines raised $300M in Series A from Bain Capital (sole investor). Clinical-stage biotech building mechanistically guided therapies for autoimmune and inflammatory diseases, anchored by a lupus program.
- Website
- www.beelinemedicines.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-04-16 09:11:19 UTC
- Signal ID
- 1160cfaa-d68a-4776-a654-45e3ad77323f
As the API returns it
{
"id": "1160cfaa-d68a-4776-a654-45e3ad77323f",
"created_at": "2026-04-16T09:11:19.920447Z",
"company_name": "Beeline Medicines",
"company_website_url": "www.beelinemedicines.com",
"company_linkedin_url": "https://www.linkedin.com/company/beelinemedicines",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Beeline Medicines raised $300M in Series A from Bain Capital (sole investor). Clinical-stage biotech building mechanistically guided therapies for autoimmune and inflammatory diseases, anchored by a lupus program.*"
}